Bristol-Myers Squibb
BMY
#168
Rank
NZ$206.70 B
Marketcap
NZ$101.50
Share price
-0.82%
Change (1 day)
-6.19%
Change (1 year)

Market capitalization of Bristol-Myers Squibb (BMY)

Market cap: NZ$206.70 Billion

As of March 2026 Bristol-Myers Squibb has a market cap of NZ$206.70 Billion. This makes Bristol-Myers Squibb the world's 168th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Bristol-Myers Squibb from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$206.70 B7.62%
2025NZ$192.06 B-7.41%
2024NZ$207.43 B25.65%
2023NZ$165.09 B-31.48%
2022NZ$240.94 B18.92%
2021NZ$202.61 B4.3%
2020NZ$194.26 B-8.52%
2019NZ$212.35 B68.74%
2018NZ$125.84 B-10.89%
2017NZ$141.22 B0.16%
2016NZ$140.99 B-15.54%
2015NZ$166.94 B34.05%
2014NZ$124.53 B17.34%
2013NZ$106.13 B64.36%
2012NZ$64.57 B-15.6%
2011NZ$76.51 B31.21%
2010NZ$58.31 B-1.85%
2009NZ$59.41 B-25.09%
2008NZ$79.31 B16.05%
2007NZ$68.34 B-6.76%
2006NZ$73.29 B11.4%
2005NZ$65.79 B-5.88%
2004NZ$69.90 B-18.1%
2003NZ$85.35 B-1.23%
2002NZ$86.41 B-64.14%
2001NZ$240.99 B-26.06%
2000NZ$325.93 B33.97%
1999NZ$243.29 B-3.64%
1998NZ$252.48 B55.9%
1997NZ$161.95 B109.8%
1996NZ$77.19 B

End of Day market cap according to different sources

On Mar 10th, 2026 the market cap of Bristol-Myers Squibb was reported to be:

NZ$206.75 Billion
by Nasdaq info icon info icon
NZ$206.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$991.39 B 379.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$527.27 B 155.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$260.69 B 26.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$677.54 B 227.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.512 T 631.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$341.62 B 65.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$179.25 B-13.28%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$46.67 B-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$488.66 B 136.41%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$510.26 B 146.86%๐Ÿ‡ฌ๐Ÿ‡ง UK